[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK1791555T3 - Fremgangsmåde til behandling af lokal tracheal, bronchial eller alveolær blødning eller hæmoptyse - Google Patents

Fremgangsmåde til behandling af lokal tracheal, bronchial eller alveolær blødning eller hæmoptyse

Info

Publication number
DK1791555T3
DK1791555T3 DK05779096.6T DK05779096T DK1791555T3 DK 1791555 T3 DK1791555 T3 DK 1791555T3 DK 05779096 T DK05779096 T DK 05779096T DK 1791555 T3 DK1791555 T3 DK 1791555T3
Authority
DK
Denmark
Prior art keywords
hemoptysis
bronchial
treating local
alveolar hemorrhage
tracheal
Prior art date
Application number
DK05779096.6T
Other languages
English (en)
Inventor
Lars Heslet
Lars Otto Uttenthal
Original Assignee
Pharmaorigin Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmaorigin Aps filed Critical Pharmaorigin Aps
Application granted granted Critical
Publication of DK1791555T3 publication Critical patent/DK1791555T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK05779096.6T 2004-09-10 2005-09-09 Fremgangsmåde til behandling af lokal tracheal, bronchial eller alveolær blødning eller hæmoptyse DK1791555T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US60875904P 2004-09-10 2004-09-10
US62297704P 2004-10-28 2004-10-28
US69396905P 2005-06-24 2005-06-24
PCT/DK2005/000576 WO2006026998A1 (en) 2004-09-10 2005-09-09 Methods for treating local tracheal, bronchial or alveolar bleeding or hemoptysis

Publications (1)

Publication Number Publication Date
DK1791555T3 true DK1791555T3 (da) 2013-06-10

Family

ID=35482229

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05779096.6T DK1791555T3 (da) 2004-09-10 2005-09-09 Fremgangsmåde til behandling af lokal tracheal, bronchial eller alveolær blødning eller hæmoptyse

Country Status (13)

Country Link
US (2) US8431535B2 (da)
EP (1) EP1791555B1 (da)
JP (2) JP2008512403A (da)
KR (1) KR101241434B1 (da)
AU (1) AU2005282065B2 (da)
BR (1) BRPI0515163A (da)
CA (1) CA2579884C (da)
DK (1) DK1791555T3 (da)
HK (1) HK1104970A1 (da)
IL (1) IL181824A (da)
MX (1) MX2007002903A (da)
NO (1) NO20071824L (da)
WO (1) WO2006026998A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007002903A (es) 2004-09-10 2007-07-11 Pharmaorigin Aps Metodos para el tratamiento de hemoptisis o hemorragias traqueales, bronquiales o alveolares, locales.
CA2612646C (en) * 2005-06-24 2015-11-24 Drugrecure Aps Airway administration of tissue factor pathway inhibitor in inflammatory conditions affecting the respiratory tract
WO2007092820A2 (en) 2006-02-03 2007-08-16 Lazarus Effect, Inc. Methods and devices for restoring blood flow within blocked vasculature
ES2399138T3 (es) 2006-03-16 2013-03-26 Stellaris Pharmaceuticals Aps Tratamiento local con factor VII
WO2010102307A1 (en) 2009-03-06 2010-09-10 Lazarus Effect, Inc. Retrieval systems and methods for use thereof
US20120141467A1 (en) * 2010-12-03 2012-06-07 Schneider Daniel J Ascorbic acid to treat chronic obstructive lung diseases and non-Hodgkin's lymphoma
WO2015006299A1 (en) * 2013-07-08 2015-01-15 Imprimis Pharmaceuticals, Inc. Pharmaceutical formulations of tranexamic acid and their use
WO2016130647A1 (en) 2015-02-11 2016-08-18 Lazarus Effect, Inc. Expandable tip medical devices and methods

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920845A (en) * 1971-08-03 1975-11-18 Beecham Group Ltd 2-nitroindan-1,3-dione
US5096916A (en) * 1990-05-07 1992-03-17 Aegis Technology, Inc. Treatment of chronic obstructive pulmonary disease (copd) by inhalation of an imidazoline
US5427797A (en) 1993-04-06 1995-06-27 Brigham And Women's Hospital Systemic effects of nitric oxide inhalation
US5980865A (en) * 1995-08-18 1999-11-09 Baker Norton Pharmaceuticals, Inc. Method for treating late phase allergic reactions and inflammatory diseases
US5690910A (en) * 1995-08-18 1997-11-25 Baker Norton Pharmaceuticals, Inc. Method for treating asthma
US5925738A (en) * 1995-12-01 1999-07-20 The American National Red Cross Methods of production and use of liquid formulations of plasma proteins
US6497877B1 (en) * 1997-01-29 2002-12-24 University Technology Corporation Plasminogen activator as an anti-inflammatory agent
SK13632000A3 (sk) * 1998-03-16 2001-03-12 Inhale Therapeutic Systems, Inc. Spôsob podávania aktívnej látky do pľúc ľudského pacienta a zariadenie na jeho vykonávanie
WO2000027360A1 (en) * 1998-11-10 2000-05-18 Byk Gulden Lomberg Chemische Fabrik Gmbh Treatment set containing lungsurfactant compositions
AU2001258230A1 (en) * 2000-05-10 2001-11-20 Novo-Nordisk A/S Pharmaceutical composition comprising a factor viia and a tfpi inhibitor
US7419949B2 (en) * 2001-07-16 2008-09-02 Novo Noridsk Healthcare A/G Single-dose administration of factor VIIa
EP1446147A1 (en) * 2001-11-09 2004-08-18 Novo Nordisk Health Care AG Pharmaceutical composition comprising factor vii polypeptides and tranexamic acid
CA2475097C (en) * 2002-02-04 2012-05-08 Salpep Biotechnology Inc. Anti-inflammatory peptides
JP4651946B2 (ja) * 2002-04-25 2011-03-16 ザ スクリプス リサーチ インスティテュート 肺病態の治療および予防
ATE488581T1 (de) * 2002-04-30 2010-12-15 Bayer Healthcare Llc Faktor vii oder faktor viia polypeptidvarianten
JP2007524607A (ja) 2003-04-09 2007-08-30 ワイス 凝固因子の吸入による血友病処置
US20040265238A1 (en) 2003-06-27 2004-12-30 Imtiaz Chaudry Inhalable formulations for treating pulmonary hypertension and methods of using same
US7404957B2 (en) * 2003-08-29 2008-07-29 Aerovance, Inc. Modified IL-4 mutein receptor antagonists
MX2007002903A (es) 2004-09-10 2007-07-11 Pharmaorigin Aps Metodos para el tratamiento de hemoptisis o hemorragias traqueales, bronquiales o alveolares, locales.

Also Published As

Publication number Publication date
IL181824A0 (en) 2007-07-04
IL181824A (en) 2012-05-31
CA2579884A1 (en) 2006-03-16
US20070258971A1 (en) 2007-11-08
JP2012092131A (ja) 2012-05-17
JP5537537B2 (ja) 2014-07-02
MX2007002903A (es) 2007-07-11
WO2006026998A1 (en) 2006-03-16
HK1104970A1 (en) 2008-02-01
US7807639B2 (en) 2010-10-05
EP1791555B1 (en) 2013-03-13
NO20071824L (no) 2007-04-10
AU2005282065A1 (en) 2006-03-16
AU2005282065B2 (en) 2013-02-07
JP2008512403A (ja) 2008-04-24
KR101241434B1 (ko) 2013-03-12
KR20070067127A (ko) 2007-06-27
US8431535B2 (en) 2013-04-30
BRPI0515163A (pt) 2008-07-08
US20070060517A1 (en) 2007-03-15
CA2579884C (en) 2013-12-31
EP1791555A1 (en) 2007-06-06
WO2006026998A8 (en) 2006-05-04

Similar Documents

Publication Publication Date Title
DK1830869T3 (da) Fremgangsmåde til behandling eller profylakse
ATE408604T1 (de) Verfahren zur herstellung von 1-alkyl-3- phenyluracilen
ATE408609T1 (de) Verfahren zur herstellung von n-phenylpyrazol-1- carboxamiden
ATE522488T1 (de) Verfahren zur herstellung von 1,2-dichlorethan
ATE533747T1 (de) Verfahren zur herstellung von tetrahydrochinolinderivaten
ATE427334T1 (de) Verfahren zur herstellung von schaumstoffplatten
ATE516816T1 (de) Verfahren zur herstellung von impfstoffen
ATE430480T1 (de) Verfahren zur herstellung von nährmittelzusammensetzungen
ATE480531T1 (de) Verfahren zur herstellung von benzopyran-2- olderivaten
DE502007002646D1 (de) Verfahren zur herstellung von difluormethylpyrazolylcarboxylaten
ATE529395T1 (de) Verfahren zur herstellung von organischen carbonaten
DE602005019848D1 (de) Verfahren zur herstellung von tad- getrocknetem ti
DE502007002159D1 (de) Verfahren zur Herstellung von Diarylcarbonat
ATE440888T1 (de) Verfahren zur herstellung von glatiramer
ATE524426T1 (de) Verfahren zur herstellung von 1,2-dichlorethan
ATE518847T1 (de) Verfahren zur herstellung von betamimetika
DK1846354T3 (da) Substituterede cyclopentaner eller cyclopentanoner til behandling af okular hypertensive tilstande
ATE444303T1 (de) Verfahren zur herstellung von ferrisuccinylcasein
IL181824A0 (en) Methods for treating local tracheal, bronchial or alveolar bleeding or hemoptysis
ATE540585T1 (de) Verfahren zur herstellung von tomatenpaste
DE602006005052D1 (de) Verfahren zur herstellung einer im wesentlichen schalenförmigen komponente
DE502006000023D1 (de) Verfahren zur Herstellung von Silanolgruppen aufweisenden Organopolysiloxanen
DK1933861T3 (da) Fremgangsmåde til behandling eller forebyggelse af multiorgansvigt
ITMI20041373A1 (it) N-metil-ammidi di carbossimetilcellulosa acido alginico o carbossimetalamido
ATE474842T1 (de) Neues verfahren zur herstellung von 5-amino-3h- thiazoloä4,5-düpyrimidin-2-on